Research paperEndomorphin-2 analogs containing modified tyrosines: Biological and theoretical investigation of the influence on conformation and pharmacological profile

Add time:08/30/2019    Source:sciencedirect.com

New analogs of the endogenous opioid agonist endomorphin-2 (EM-2, H-Tyr-Pro-Phe-Phe-NH2) have been obtained by introducing modified tyrosines at the position 1 of the sequence. For all analogs, the cis/trans conformation ratio about the tyramine-Pro amide bond, lipophilicity, receptor affinities, and functional activities, have been determined. Among the novel derivatives, [Dmt(3′-Cl)]1EM-2 (4) stood out for its subnanomolar μ-opioid receptor affinity and potent agonist activity, superior to that of the parent peptide EM-2. Hybrid quantum mechanics/molecular mechanics docking computations supported the cis tyramine-Pro bioactive conformation, and allowed us to analyze the contribution of the substituents of the “message” tyramine to binding, highlighting the role of halogen-bonding in the higher receptor affinity of peptide 4.

We also recommend Trading Suppliers and Manufacturers of CIS-2-AMINO-1-CYCLOPENTANECARBOXYLIC AC& (cas 18414-30-7). Pls Click Website Link as below: cas 18414-30-7 suppliers

Prev:Coordination compounds of ethylhydrazine (cas 18413-14-4) and 2,2,2-Trifluoroethylhydrazine (cas 18413-14-4); crystal and molecular structure of dichlorotetrakis(2,2,2-Trifluoroethylhydrazine (cas 18413-14-4)) nickel(II)
Next:SANGIVAMYCIN (cas 18417-89-5) induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells)